Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer

A hybrid gene selection approach to create the S1500+ targeted gene sets for use in high-throughput transcriptomics

(2018) Deepak Mav et al.   PLoS One

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer

(2017) Andrew J. Armstrong et al.   EUROPEAN JOURNAL OF CANCER

Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways

(2017) Ewelina Górowska-Wójtowicz et al.   TOXICOLOGY IN VITRO

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone

(2016) Kathleen C. Day et al.   CANCER RESEARCH

Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway

(2015) Urszula L. McClurg et al.   Oncotarget

Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer

(2014) Richard Schroeder et al.   MOLECULES

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients

(2013) J M Willder et al.   BRITISH JOURNAL OF CANCER

An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)

(2013) M. Korpal et al.   Cancer Discovery

The androgen receptor gene mutations database: 2012 update

(2012) Bruce Gottlieb et al.   HUMAN MUTATION

Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5

(2011) Fu-Ning Hsu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

(2009) A M Traish et al.   BRITISH JOURNAL OF CANCER

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

(2009) Qianben Wang et al.   CELL

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

(2009) Alyse M. DeHaan et al.   PROSTATE

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

(2008) P McCall et al.   BRITISH JOURNAL OF CANCER

Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer

(2008) Liliana A. Ponguta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

(2008) C. A. Maxwell et al.   JOURNAL OF CELL SCIENCE